Company profile: Syntactx
1.1 - Company Overview
Company description
- Provider of global clinical research services specializing in complex clinical trials, offering consulting across all phases, biostatistics and statistical programming, clinical evidence and post-market studies, clinical trial safety with in-house medical monitors and MeDRA coders, data management and EDC, and field clinical engineering staffing.
Products and services
- Biostatistics & Statistical Programming: Custom-designed biostatistics programs architect clinical trial study design, conduct data analysis, and produce statistical reporting, supporting robust planning and assessment
- Clinical Evidence & Post-Market Studies: Meta-analytic clinical evidence and post-market activities justify and differentiate product claims by conducting meta-analysis and patient registry studies to document outcomes captured in patient registries
- Clinical Research Consulting: Customized clinical research consulting architects study design, develops protocols, and manages clinical trial operations across all phases of clinical research
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Syntactx
CenExel
HQ: United States
Website
- Description: Provider of clinical research site network services supporting phase I-IV clinical trials, offering medical and scientific services to assist in the design and execution of clinical studies. Operates multiple centers across the country, delivering comprehensive resources to enhance research outcomes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CenExel company profile →
Lisapharma
HQ: Italy
Website
- Description: Provider of sterile injectable medicines and contract manufacturing for sterile and non-sterile products (liquids, semi-solids, medical devices). Offers pharmacovigilance; R&D (analytical method development, forced degradation, product characterization, stability); and quality control (chemical-physical, microbiological, packaging analysis). Acurmil (Atracurium Besilate) IV injectable muscle relaxant. Based in Erba, Italy; active in 40+ countries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lisapharma company profile →
Senn Chemicals
HQ: Switzerland
Website
- Description: Provider of peptide development and manufacturing services, spanning intermediates to CGMP API and supporting discovery through commercial production. In the peptide business since 1963, SENN offers expertise to optimize processes and streamline scale-up.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Senn Chemicals company profile →
Nivagen Pharmaceuticals
HQ: United States
Website
- Description: Provider of generic prescription drugs and over-the-counter healthcare products for the North American market, engaged in development, acquisition, and sales. Leverages global partnerships with FDA-approved manufacturers to deliver affordable, high-quality products, including Carbamazepine, Celecoxib, Chlorthalidone, and Diclofenac Sodium/Misoprostol.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nivagen Pharmaceuticals company profile →
Gelpell
HQ: Switzerland
Website
- Description: Provider of manufacturing for food supplements and nutrients, offering soft gelatin capsules for oily and semi-solid preparations; Gelpell® beads for slow, even release and improved bioavailability; hard capsules with powders or Gelpell® beads; plant-based pea-starch soft capsules; blister packaging compliant with pharmaceutical standards; and bulk product supply.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gelpell company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Syntactx
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Syntactx
2.2 - Growth funds investing in similar companies to Syntactx
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Syntactx
4.2 - Public trading comparable groups for Syntactx
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →